R. Neil A. Black

The peroxisome proliferator-activated receptor alpha agonist fenofibrate has no effect on insulin sensitivity compared to atorvastatin in type 2 diabetes mellitus; a randomised, double-blind controlled trial.

I. Young, S. Hunter, A. Atkinson, 2014, Journal of diabetes and its complications.